Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
---|
06/23/1991 | WO1991009946A1 Method of preparation of hirudin |
06/23/1991 | WO1991009945A1 Neutrophil chemoattractants |
06/23/1991 | WO1991009935A1 Matrix with adherently bound cells and process for producing viruses/virus antigens |
06/23/1991 | WO1991009871A1 Hybrid molecules having translocation region and cell-binding region |
06/23/1991 | CA2572802A1 Cytotoxic lymphocyte maturation factor and monoclonal antibodies directed thereto |
06/23/1991 | CA2072012A1 Neutrophil chemoattractants |
06/23/1991 | CA2071969A1 Hybrid molecules having translocation region and cell-binding region |
06/23/1991 | CA2070399A1 Polypeptides and dna coding therefor |
06/23/1991 | CA2066442A1 Method of preparation of hirudin |
06/22/1991 | WO1991009968A1 Cd3 specific recombinant antibody |
06/22/1991 | WO1991009965A1 An improved toxin for construction of immunotoxins |
06/22/1991 | WO1991009939A1 Transformed cell lines |
06/22/1991 | CA2071998A1 Transformed cell lines |
06/22/1991 | CA2071946A1 Toxin for construction of immunotoxins |
06/21/1991 | WO1991009127A1 BCRF1 PROTEINS AS INHIBITORS OF INTERFERON-$g(g) |
06/20/1991 | WO1991009126A1 Production of human basic fgf mutein |
06/20/1991 | CA2070989A1 Production of human basic fgf mutein |
06/20/1991 | CA2032675A1 Platelet-derived growth factor b chain analogs and method for homogeneous production thereof |
06/19/1991 | WO1991009129A1 Stable integration of dna in bacterial genomes |
06/19/1991 | EP0433225A1 Process for the production of biologically active protein (e.g. TGF) |
06/19/1991 | EP0433088A1 Monoclonal antibodies reactive with a human atheroma associated antigen |
06/19/1991 | EP0432965A1 Malaria vaccine |
06/19/1991 | EP0432510A1 Process for the preparation of genetic vectors for the nerve growth factor expression in eukaryotic cells |
06/19/1991 | EP0432490A2 Immunostimulant agent |
06/19/1991 | EP0432254A1 NUCLEIC ACID CODING FOR THE HUMAN TESTICULAR ANGIOTENSIN CONVERSION ENZYME (ECA) AND ITS APPLICATIONS, IN PARTICULAR FOR THE $i(IN VITRO) DETECTION OF SAID ENZYME IN THE ORGANISM |
06/19/1991 | EP0254735B1 Thermally stable and ph stable subtilisin analogs and method for production thereof |
06/19/1991 | EP0203967B1 Onco-fetal specific monoclonal antibodies, methods of preparation and use |
06/19/1991 | EP0201540B1 Envelope antigens of lymphadenopathy associated virus and their applications |
06/19/1991 | EP0179872B1 Bispecific antibody determinants |
06/19/1991 | CN1052332A Process for producing des(64,65)-proinsulin |
06/19/1991 | CN1052331A Novel antigens and methods therefor |
06/19/1991 | CA2070676A1 Stable integration of dna in bacterial genomes |
06/19/1991 | CA2032405A1 Organic compounds |
06/18/1991 | US5024947 Containing a basal medium, a lipid, a peptone and a protective agent |
06/18/1991 | US5024946 Human monoclonal antibody to antigen of gastric cancer and B-cell line for producing this antibody, method for preparing this B-cell line and antibody, antigen and method of preparation of this antigen |
06/18/1991 | US5024943 Regulatory region cloning and analysis plasmid for bacillus |
06/18/1991 | US5024941 Genetic engineering |
06/18/1991 | US5024939 Transient expression system for producing recombinant protein |
06/18/1991 | US5024938 Culturing |
06/18/1991 | US5024837 Bacillus thuringiensis with acquired toxin-encoding plasmid; genetic engineering |
06/18/1991 | US5024835 Conjugates of a vinca derivative carrying a detergent chain in the C-3 position |
06/18/1991 | CA1284959C Dna sequence useful for the production and secretion from yeast of peptides and proteins |
06/16/1991 | WO1991009134A1 Biospecific antibody to cancer cell and enzyme with prodrug-activating characteristics |
06/16/1991 | WO1991008774A1 Cytokine antibody for the treatment of sepsis |
06/16/1991 | CA2071872A1 Cytokine antibody for the treatment of sepsis |
06/16/1991 | CA2069439A1 Monoclonal antibodies, their production and use |
06/16/1991 | CA2032359A1 Monoclonal antibodies reactive with a human atheroma associated antigen |
06/16/1991 | CA2031831A1 Production method for foreign protein |
06/14/1991 | CA2071858A1 Hiv-1 env fragment fusion protein |
06/13/1991 | WO1991008505A1 Stereoscope |
06/13/1991 | WO1991008488A1 Trypsin inhibitor (alpha, at) peptide, immunoassay, monoclonal antibody and hybridoma |
06/13/1991 | WO1991008478A2 METHODS OF DETECTING COLLAGEN DEGRADATION $i(IN VIVO) |
06/13/1991 | WO1991008303A1 Antibody against human double-stranded tissue plasminogen activator |
06/13/1991 | WO1991008302A1 Monoclonal antibodies specific for acetyl cholinesterase |
06/13/1991 | WO1991008298A2 Fusion proteins consisting of a ligand binding protein and a stable plasma protein |
06/13/1991 | WO1991008296A1 Cdna of orsv gene |
06/13/1991 | WO1991008291A2 Latency associated peptide and uses therefor |
06/13/1991 | WO1991008231A1 [Ala IL-8]77 AS A LEUKOCYTE ADHESION INHIBITOR |
06/13/1991 | WO1991008229A1 Hirudine polyalkylene glycol conjugates |
06/13/1991 | WO1991008228A1 Leucocyte elastasis and cathepsin g-blocking peptide |
06/13/1991 | WO1991008214A1 Dna segment encoding a gene for a receptor related to the epidermal growth factor receptor |
06/13/1991 | WO1991002062A3 C-erbb-2 external domain: gp75 |
06/13/1991 | DE3940527A1 Prodn. of HIV-1 regulatory protein NEF |
06/12/1991 | EP0432134A1 Hybridoma cell lines and monoclonal antibodies |
06/12/1991 | EP0431926A1 Process for producing des(64,65)-proinsulin |
06/12/1991 | EP0431880A1 Mutant fungal strain detection |
06/12/1991 | EP0431679A1 Method of stabilizing recombinant hepatitis B virus surface proteins from yeast |
06/12/1991 | EP0431668A1 Recombinant herpesvirus of turkeys and live vector vaccines derived thereof |
06/12/1991 | EP0431541A2 Toxoplasma gondii antigen, its production and use |
06/12/1991 | EP0431350A1 New polypeptide compound and a process for preparation thereof |
06/12/1991 | EP0431171A1 Monoclonal antibody against c-reactive protein |
06/12/1991 | EP0431125A1 Process for producing human monoclonal antibodies |
06/12/1991 | EP0431069A1 Dna sequences, recombinant dna molecules and processes for producing pi-linked lymphocyte function associated antigen-3 |
06/12/1991 | EP0431065A1 A FULL LENGTH cDNA ENCODING A HUMAN LAMININ BINDING PROTEIN |
06/12/1991 | EP0431060A1 Method of catalyzing stereochemical reactions |
06/12/1991 | EP0431042A1 A method of preparing an active human neutrophil chemotactic factor polypeptide. |
06/12/1991 | EP0430999A1 Monoclonal antibody for inhibiting cell infection by hiv viruses |
06/12/1991 | CN1052144A Compounds and methods for treatment and diagnosis of cancer |
06/12/1991 | CN1052141A Neurotrophin-3, neurotrophic factor related to nerve growth and brain derived neurotrophic factor |
06/12/1991 | CA2031763A1 Process for purification of a 69000 dalton antigentic protein from bordetella pertussis |
06/09/1991 | WO1991009133A1 Recovery of bt endotoxin protein from lysed cell mixtures |
06/09/1991 | CA2070649A1 Recovery of bt endotoxin protein from lysed cell mixtures |
06/09/1991 | CA2031468A1 Malaria vaccine |
06/08/1991 | WO1991009125A1 Proteins and nucleic acids |
06/08/1991 | WO1991009118A2 Activatable fibrinolytic and anti-thrombotic proteins |
06/08/1991 | CA2069105A1 Proteins and nucleic acids |
06/08/1991 | CA2031390A1 Process for producing des(64,65)-proinsulin |
06/05/1991 | WO1991007986A1 Method of treating septic shock |
06/05/1991 | EP0430645A2 Vaccines |
06/05/1991 | EP0430270A1 Method for the biological inactivation of nucleic acids |
06/05/1991 | EP0430193A1 Monoclonal antibodies and their use |
06/05/1991 | EP0429816A1 Vaccine composition with non-immunosuppresive T-cell epitope component |
06/05/1991 | EP0429788A2 Fragments of porcine somatotropin and antibodies thereto enhancing porcine somatotropin activity |
06/05/1991 | EP0429628A1 Dna sequences, vectors, and fusion polypeptides to increase secretion of desired polypeptides from filamentous fungi |
06/05/1991 | EP0429600A1 Saf polypeptide, gene, promoter and use for expression in streptomyces |
06/05/1991 | EP0429587A1 Process for obtaining a regulation protein (nef) for hiv-1 using the human cell line th4-7-5. |
06/05/1991 | EP0429544A1 Synthetic, anti-complement protein and the gene encoding same |
06/05/1991 | EP0429502A1 O-glycosylated igf-1 |
06/05/1991 | EP0429484A1 Porcine polyclonal and monoclonal antibodies |
06/05/1991 | EP0429470A1 Antibody recognition of fragments from cytomegalovirus |